Taking a GLP-1 After Gallbladder Removal: What Changes

If your gallbladder has already been removed, one of the more discussed GLP-1 risks stops applying to you. The largest meta-analysis of randomized trials found these drugs raise the risk of gallbladder and biliary disease — with a notably higher risk in weight-loss trials than diabetes trials ^[1]. Without a gallbladder you cannot develop gallstones or cholecystitis in it. What remains is a different question: whether a drug that slows digestion interacts with the loose stool that some people get after the operation ^{[2] [4]}. Those two things get confused constantly.

The honest summary

• The gallbladder risk is well quantified, and higher for weight loss. Across 76 trials and 103,371 patients, GLP-1 drugs raised gallbladder or biliary disease risk with a relative risk of 1.37. In weight-loss trials specifically it was 2.29, against 1.27 in diabetes trials ^[1].
• Dose and duration matter. Higher doses carried a relative risk of 1.56 versus 0.99 at lower doses, and longer use 1.40 versus 0.79 for shorter use ^[1].
• Once the gallbladder is gone, that specific risk is gone. Cholelithiasis and cholecystitis, the two largest contributors, require a gallbladder.
• Bile acid diarrhea after cholecystectomy is real but not universal. Post-cholecystectomy diarrhea has been reported in 2.1% to 57.2% of patients, and only a fraction of those cases are truly bile acid diarrhea ^[2].
• Most people who have had the operation tolerate these drugs normally. There is no contraindication, and constipation is at least as common a GLP-1 effect as diarrhea.

What the gallbladder evidence actually says

The definitive analysis is a 2022 systematic review and meta-analysis in JAMA Internal Medicine covering 76 randomized trials and 103,371 patients ^[1]. GLP-1 treatment was associated with increased risk of the composite of gallbladder or biliary disease, relative risk 1.37 (95% CI 1.23 to 1.52). Broken down: cholelithiasis 1.27, cholecystitis 1.36, biliary disease 1.55.

The subgroup finding is the one that matters for anyone taking these drugs for weight. In the thirteen weight-loss trials the relative risk was 2.29 (95% CI 1.64 to 3.18), against 1.27 in the sixty-three diabetes and other trials, with a significant interaction ^[1]. Risk was also higher at higher doses and with longer duration ^[1]. Rapid weight loss is itself a classic cause of gallstones, which is the most likely explanation for that gap.

Tirzepatide has been examined separately, with a 2023 review looking specifically at pancreatitis and gallbladder or biliary disease in type 2 diabetes and obesity trials ^[5]. The direction of the concern is the same.

What actually changes without a gallbladder

The gallbladder stores and concentrates bile and releases it in a bolus when you eat fat. Without one, bile drips continuously into the small intestine instead. Most people adapt within weeks to months. A minority do not, and bile reaching the colon draws in water and causes urgent, watery diarrhea — bile acid diarrhea.

How common is it? A multicenter audit of 9,439 laparoscopic cholecystectomies found only 202 patients (2.1%) were investigated for diarrhea, of whom 62.8% were diagnosed with bile acid diarrhea ^[2]. The authors note that reported post-cholecystectomy diarrhea ranges from 2.1% to 57.2% across the literature but is not necessarily bile acid diarrhea. A separate prospective case-control study examined bile acid diarrhea alongside metabolic changes after the operation ^[3], and a 2025 narrative review covers post-cholecystectomy syndrome more broadly ^[4].

How that interacts with a GLP-1

No study has tested GLP-1 drugs specifically in people who have had a cholecystectomy, so this part is reasoning from mechanism rather than trial data, and it should be read that way. GLP-1 drugs slow gastric emptying and gut motility. In someone with bile acid diarrhea, slower transit is not obviously bad — it could reduce urgency. Constipation is a more common GLP-1 effect than diarrhea overall.

The practical complication is that if you do get diarrhea after starting, you now have two candidate explanations and telling them apart matters. Bile acid diarrhea typically responds to a bile acid binder; GLP-1 diarrhea usually settles as you stay on a dose. That is a conversation for your prescriber, not a reason to abandon either.

Practical guidance

• Having had your gallbladder out is not a reason to avoid a GLP-1. It removes the main organ-specific risk ^[1].
• Tell your prescriber about the operation and when it was, particularly if you still have loose stool from it.
• If you already have bile acid diarrhea, get it properly diagnosed first so that any change after starting is interpretable ^[2].
• Expect constipation at least as much as diarrhea. It is the more common GLP-1 bowel effect.
• Right-upper abdominal pain still needs assessment. Bile duct stones remain possible after the gallbladder is gone.
• If you still have your gallbladder, the risk is dose and duration related and highest during rapid weight loss ^[1].